System and method for regulating fluid infusion into patient
Patent Information
- Application Number
- JP2021196282
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-07-01
- Filing Date
- 2021-12-02
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2041-12-02
AI Technical Summary
Manual management of medication administration during surgery is challenging, leading to frequent deviations from target vital sign ranges, with high costs and risks due to constant professional attention, resulting in hypotension and hypertension issues.
A closed-loop infusion system that uses a supervisory algorithm to adjust medication delivery rates based on real-time vital sign monitoring, maintaining patient vital signs within target ranges by calculating modified dose rates and implementing safeguards to ensure safety.
The system effectively maintains patient vital signs within target ranges, reducing hypotensive and hypertensive episodes, minimizing medication usage, and ensuring stable blood pressure during surgery.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
Technical Field
[0001] Cross - reference to Related Applications This application claims the priority of U.S. Patent Application No. 17 / 365,730, filed on July 1, 2021, which claims the priority of U.S. Provisional Patent Application No. 63 / 199,034, filed on December 3, 2020. All of these and all other referenced external materials are incorporated herein by reference in their entirety. If the definition or usage of a term in a reference incorporated by reference conflicts with or is contrary to the definition of that term given herein, the definition of that term given herein shall control.
[0002] The field of the present invention is systems and methods for closed - loop infusion, particularly systems and methods used with an intravenous infusion pump.
Background Art
[0003] The following description includes information that may be useful for understanding the present invention. This is not to say that all of the information provided herein is prior art or relevant to the claimed invention, nor is it to say that all publications explicitly or implicitly referenced are prior art.
[0004] It may be difficult to maintain a patient's blood pressure and other vital signs, and inadequate management can affect the patient's health. Hypotension can occur frequently during surgery, and this hypotension is associated with an adverse impact on the patient's outcome. For example, if a patient's mean arterial pressure (MAP) drops by 55 - 65 mmHg for just one minute during surgery, the risk of death is increased compared to when the patient's blood pressure remains stable.
[0005] Unfortunately, manually managing medication to maintain blood pressure and other vital signs during surgery can be challenging. Optimizing blood pressure or other vital signs requires repeatedly taking measurements of the patient's vital signs and frequently manually adjusting the rate of drug administration. This can be prohibitively expensive and impractical, as it typically requires constant monitoring by a medical professional.
[0006] Figure 1 shows a typical workflow for manually maintaining a patient's vital signs. A nurse or other healthcare professional monitors the patient's vital signs and manually adjusts the rate of medication administration. Because healthcare professionals often care for multiple patients at once, checks on each patient's vital signs are performed periodically but not frequently, thus missing opportunities for further correction. Furthermore, adjustments may be made arbitrarily based on a momentary impression of the patient's vital signs.
[0007] In the case of blood pressure, such manual management often results in patients being outside their target range for a considerable amount of time. For example, one study found that as a result of manual blood pressure management, patients were outside the target range for more than 50% of the time, experiencing hypotension (below the target range) for 10-15% of the time and hypertension (above the target range) for 30-40% of the time.
[0008] All published documents expressed herein are incorporated by reference to the same extent that each individual published document or patent application is specifically and individually indicated by reference. If a definition or usage of a term in an incorporated reference document is inconsistent with or contrary to the definition of that term given herein, the definition given herein shall apply, and the definition in the reference document shall not apply.
[0009] Therefore, there is a continued need for closed-loop systems and methods that continuously optimize the rate of drug administration given to patients over time. [Overview of the project] [Problems that the invention aims to solve]
[0010] This invention was made to solve the problems of the above-mentioned conventional technology. [Means for solving the problem]
[0011] The present invention provides devices, systems, and methods for adjusting the flow rate of a drug or other fluid to a patient. Patient information, such as one or more vital signs, may be received from at least one source (including, for example, a transducer or other sensor). Target values and / or target ranges for one or more of those vital signs may be received. In one embodiment, the target values and / or target ranges may be entered using a graphical user interface. The initial administration rate of the drug or other fluid to be administered to the patient may also be received.
[0012] Such vital signs may include, for example, the patient's mean arterial pressure, but may also include any other vital signs that can be managed by intermittent fluid administration of medication, such as through the use of an intravenous fluid infusion device.
[0013] Based on information received about a patient, such as one or more vital signs, a first control algorithm may be used to generate a modified administration rate for the delivery of a drug or other fluid to the patient. The first control algorithm compares the value of a first vital sign to a target value, calculates the difference, and generates a modified administration rate as a function of the initial (first) or current administration rate and the difference. Once a modified administration rate is generated, the drug may be delivered to the patient according to that modified administration rate. The first control algorithm may be configured to constantly monitor patient information (e.g., one or more vital signs) to maintain the patient's vital signs within a target range (i.e., a predetermined range from the target value of the vital signs) and to modify the administration rate of the drug or other fluid as needed.
[0014] In another embodiment, a non-transient computer-readable medium stores a computer program containing commands that cause a processor to perform a method for adjusting the flow rate of medication to a patient. The program may receive (i) the patient's first vital signs from a first source, and (ii) information regarding target values for the first vital signs. It may also receive the initial or current administration rate of the medication being administered to the patient.
[0015] The processor may execute a computer program to calculate the difference between the current value of a first vital sign and a target value or target range, and then generate a modified administration rate for drug delivery to the patient as a function of the initial (first) or current administration rate and the difference. Once the modified administration rate is generated, the drug may be delivered to the patient according to that modified administration rate.
[0016] Various purposes, features, embodiments, and advantages of the present invention will become further apparent when the following detailed description of preferred embodiments is read in conjunction with the accompanying drawings. In the accompanying drawings, similar reference numerals represent similar components. [Brief explanation of the drawing]
[0017] [Figure 1] A flowchart of prior art for manual adjustment of patient vital signs is shown. [Figure 2] This shows a flowchart for the automatic adjustment of patient vital signs. [Figure 3] A diagram illustrating one embodiment of a method for adjusting the flow rate of medication to a patient is shown. [Figure 4] An exemplary embodiment of the first management algorithm is shown. [Figure 5] An exemplary embodiment of the rule engine is shown. [Figure 6] This example shows a comparison of the time spent within the target range for patients using manual management versus patients using automated management. [Figure 7] This document illustrates one embodiment of a system for automatically adjusting a patient's vital signs. [Modes for carrying out the invention]
[0018] Throughout the following discussion, various references may be made to servers, services, interfaces, portals, platforms, or other systems formed by computing devices. Naturally, the use of such terms is understood to refer to one or more computing devices having at least one processor configured to execute software instructions stored on a computer-readable, tangible, non-temporary medium. For example, a server may include one or more computers operating to perform the described roles, tasks, or functions, such as a web server, database server, or other type of computer server.
[0019] The following discussion provides various exemplary embodiments of the subject matter of the present invention. Each embodiment represents one combination of the elements of the invention, but the subject matter of the present invention is considered to encompass all possible combinations of the elements disclosed. Thus, if one embodiment includes elements A, B, and C, and another embodiment includes elements B and D, the subject matter of the present invention is further considered to encompass other remaining combinations of A, B, C, or D, even if not expressly disclosed.
[0020] FIG. 2 shows a simplified flowchart of the automatic adjustment of a patient's vital signs using automatic adjustment of the administration rate of a drug to the patient based on changes in one or more monitored vital signs of the patient.
[0021] FIG. 3 shows a first embodiment 100 of a method of adjusting the flow rate of a drug 122 to a patient 114. The target value of the first vital sign and the initial (first) or current administration rate of the drug 122 administered to the patient 114 may be received, such as by input to a graphical user interface 116.
[0022] Information 112 regarding the first vital sign of the patient 114 may be received from a first source 110, which may be received directly from a sensor or the like, or indirectly from a patient monitoring device or the like. Based on the received information 112, a modified administration rate 118 may be generated by a first management algorithm. Next, according to the modified administration rate, the drug 122 may be delivered to the patient 114 by an infusion pump 120 or the like. In this way, the first vital sign of the patient 114 can be monitored periodically and constantly, and the administration rate of the drug 122 can be adjusted according to the difference between the first vital sign and the target value or target range and other factors. In some embodiments, in adjusting the administration rate, the initial (first) or current administration rate, the value of the difference between the current vital sign and the target value or target range, and a scalar rate associated with the drug 122 may be considered. Although a vasopressor is illustrated as the drug, it is contemplated that the systems and methods described herein may be used for any other drug used to manage one or more vitals of a patient and may be used with drugs that are intermittently infused into the patient.
[0023] In some contemplated embodiments, a processor executes a first management algorithm that compares the value of the patient's first vital sign to a target value or target range to calculate a value of the difference and generates a modified administration rate as a function of the initial (first) or current administration rate and the value of the difference.
[0024] In one embodiment, the system and method described herein may be used to regulate a patient's blood pressure, which is done, for example, by controlling the administration rate of a vasopressor administered intermittently to the patient. In such an embodiment, the first vital sign may include the patient's mean arterial pressure (MAP), which can be measured using a transducer attached to the patient. The system and method is preferably configured to maintain the patient's first vital sign within a target range of a target value (e.g., within 5 mmHg) by monitoring and tracking the patient's MAP and using a first control algorithm to generate a modified administration rate in response to changes in the patient's MAP. The modified administration rate may be sent, for example, to an IV infusion device, which is capable of changing the administration rate of the drug being administered to the patient.
[0025] Furthermore, it is intended that additional safety precautions may be used to help prevent the systems and methods described herein from masking a deterioration in the patient's condition by maintaining the patient's blood pressure or other vital signs, such as by continuously increasing the drug administration rate. In such an embodiment, the initial (first) administration rate, a set of preceding administration rates, the current administration rate (if applicable), and a modified administration rate may be stored in memory communicably coupled to a processor, and the stored set of drug administration rates to the patient may be analyzed by the processor. If the frequency of changes in the drug administration rate over a period of time exceeds a predetermined threshold, an alarm command may be generated to notify the medical team of the possibility that the patient's condition is deteriorating despite the patient's vital signs remaining within the target range.
[0026] As an additional or alternative safety measure, another available safeguard is to stipulate that further adjustments to the administration rate cannot be made until a certain amount of time has elapsed since the last change in the drug's administration rate. For example, in the step of generating the modified administration rate, it is intended that a first time is determined, measured as the time elapsed since the last change in the drug's administration rate. If this first time is shorter than a certain minimum time, the administration rate is not changed. Conversely, if the first time is longer than or equal to that minimum time, the modified administration rate may be set as the initial (first) or current administration rate of the drug to the patient.
[0027] In such embodiments, the minimum time is preferably longer than the tubing delay of the delivered drug, which can be calculated by knowing the length of the pipe through which the drug must flow from the drug source to the patient and the flow rate of the drug through the pipe. This can be a rough estimate. Importantly, the administration rate is not changed by the system and method unless the patient has actually received the drug at the previous administration rate. Since the tubing delay can be 1-2 minutes or more depending on the circumstances, this safety measure helps to ensure that the system and method do not overcompensate by adjusting the drug administration rate without considering the tubing delay, but rather allow sufficient time for the administration rate to change.
[0028] To further ensure that the closed-loop system and method are safe for the patient, it is preferable that the minimum and maximum drug administration rates be entered according to the patient. If this is not done, the system and method are intended to be able to request this information from a healthcare professional or to have available default values that may depend on the drug being delivered to the patient.
[0029] In such embodiments, the first control algorithm is intended to be able to determine whether the modified dosing rate is greater than the minimum dosing rate and less than the maximum dosing rate. If not, the initial (first) or current dosing rate may be maintained (without adjustment), and the drug may be delivered to the patient according to the initial (first) or current dosing rate. In such cases, an alarm status may be generated to alert a healthcare professional of the problem. Alternatively, the modified dosing rate may be adjusted from the current dosing rate to the minimum or maximum dosing rate (if applicable), and an alarm status may be generated.
[0030] In yet another embodiment, the system and method are intended to be able to further ensure that the amount of change in the administration rate does not exceed a certain amount (upper change threshold) in any single adjustment. For example, the first control algorithm is intended to be able to calculate the difference between the modified administration rate and the initial (first) or current administration rate before delivering the drug to the patient according to the modified administration rate. If the difference between these two administration rates exceeds the upper change threshold, the modified administration rate may instead be set to the initial (first) or current administration rate plus the upper change threshold. Thus, in such an embodiment, the administration rate is changed, but only by the amount of the upper change threshold. In such cases, it is further intended that an alarm status may be generated to alert a healthcare professional of the problem.
[0031] Furthermore, it is intended that the first vital sign may be monitored separately from a second source in addition to the first source. Information on the first vital sign may be received from the second source, and the information received from the second source may be compared with the information on the first vital sign received from the first source. If the difference between the information from the first source and the information from the second source exceeds a predetermined threshold, an alarm command may be generated. Even if the units of the measured vital signs differ between those measured by the first source and those measured by the second source, it is intended that the information received from one source may be converted so that the values can be compared. For example, in the case of blood pressure monitoring, it is intended that the first source may monitor the patient's MAP, and the second source may monitor the patient's systolic blood pressure (SBP) and diastolic blood pressure (DBP). In such a situation, systolic blood pressure may be converted to MAP by the following formula. MAP = (SBP + 2 * (DBP)) / 3
[0032] In addition to the primary vital signs, other vital signs of the patient may be monitored, such as, for example, oxygen saturation (SpO2), body temperature, and electrical signals from the heart (EKG). Additionally or alternatively, perfusion and / or metabolic activity within the patient may also be monitored.
[0033] As merely one embodiment, when monitoring a patient's blood pressure, the first source may be a transducer attached to the patient, and the second source may be a blood pressure monitor configured to monitor systolic blood pressure.
[0034] In another embodiment, a non-temporary computer-readable medium containing a computer program is provided. Preferably, the computer program includes commands that cause a server processor to perform a method for adjusting the flow rate of medication to the patient. Thus, for example, an intravenous infusion device may include a processor which is communicatively coupled to a non-temporary computer-readable medium containing a computer program which may include the first management algorithm described above. The intravenous infusion device may be a management unit that monitors and calculates the infusion rate, or an independent management unit may communicate with the intravenous infusion device to manage the infusion rate of medication to the patient.
[0035] The computer program may be configured to receive information from a first source regarding the patient's first vital sign via a management unit. The target value for the first vital sign, and the initial (first) or current administration rate of the medication being administered to or currently being administered to the patient may also be received via a GUI or the like connected to the management unit.
[0036] Based on the received information, the processor of the control unit may execute a computer program to compare the value of the first vital sign with a target value or target range and calculate the difference. Next, based on the initial (first) or current infusion rate and the difference value, a modified infusion rate may be generated and sent to the infusion device for drug delivery to the patient, and the current infusion rate may be adjusted to the modified infusion rate.
[0037] Next, the drug may be delivered to the patient by the infusion device according to the modified administration rate.
[0038] In some embodiments, the first vital sign may include the patient's mean arterial pressure, and the drug may include a vasopressor. In such embodiments, the first source may be a patient-attached transducer or another sensor capable of measuring the patient's MAP or other blood pressure indicators.
[0039] The first administration rate, the previous administration rate, the current administration rate (if applicable), and the modified administration rate may be stored on the same non-temporary computer-readable medium or on separate non-temporary computer-readable mediums. The stored set of drug administration rates may be analyzed, and an alarm command may be generated if the frequency of changes in administration rates over a certain period of time exceeds a predetermined threshold.
[0040] As described above, various other safety measures may be implemented in the computer program to ensure that the adjustment of the administration rate is safe for the patient. Examples include setting a minimum and maximum administration rate of the drug, limiting the frequency at which the administration rate can be adjusted, and / or setting a maximum value for the amount of each adjustment of the administration rate.
[0041] Therefore, for example, generating a modified administration rate is intended to first determine whether at least a predetermined time length or minimum time has elapsed since the last administration rate change, and if not, the administration rate may remain unchanged. If the elapsed time exceeds the minimum time, the administration rate may be adjusted. Preferably, in such embodiments, the minimum time may be greater than or equal to the tubing delay present when the drug is being administered to the patient. As described above, this tubing delay is based on the length of the tubing measured from the drug source to the patient and the flow rate of the drug through the tubing.
[0042] Furthermore, generating a modified infusion rate may include calculating the difference between the modified infusion rate and the initial (first) or current infusion rate. If the difference between the current infusion rate and the modified infusion rate exceeds the upper limit change threshold, the modified infusion rate may be set to the initial (first) or current infusion rate plus the upper limit change threshold.
[0043] Furthermore, various systems are envisioned for adjusting the flow rate of medication to the patient. In Figure 7, one embodiment of the system 200 may include a control unit 220, in which a processor 222 is communicatively coupled to a memory 224, the memory 224 is configured to store a first control algorithm. The control unit 220 is configured to receive information from a first source regarding the patient 240's first vital signs, target values or target ranges of the first vital signs, and the initial (first) or current administration rate for intermittent delivery of medication to the patient. The medication may be delivered by an infusion device, which may or may not include the control unit 220.
[0044] If vital signs are outside the target range, the control unit 220 uses a first control algorithm to generate a modified infusion rate for drug delivery to patient 240. The first control algorithm is programmed to compare the first vital sign values with target values or target ranges, calculate the difference, and generate a modified infusion rate based on the initial (first) or current infusion rate and the difference. For example, if the patient's vital signs exceed the target value or target range, the difference between the vital signs and the target value or target range may be calculated (difference). The control unit may then calculate the additional amount of drug (increase in infusion rate) needed to bring the vital signs back within the target range. This increase in infusion rate may then be added to the current infusion rate to generate a modified infusion rate.
[0045] Next, the control unit 220 may send a command signal to ensure that the drug is delivered from the infusion pump 230 to the patient 240 at a modified administration rate.
[0046] In some intended embodiments, the first vital signs include the mean arterial pressure of patient 240, and the first source includes a transducer fitted to patient 240.
[0047] Furthermore, the control unit 220 may store the initial administration rate, the history of adjustments to the administration rate, or modified administration rates, and may analyze the stored administration rates of the drug to the patient 240. If the frequency of changes in the administration rate over a certain period of time exceeds a predetermined threshold, the control unit 220 may generate an alarm command.
[0048] As described above, various other safety measures to ensure that the administration rate is safe for patient 240 may be implemented in the control algorithm of the control unit 220. For example, this may include setting a minimum and maximum administration rate, limiting the frequency of adjusting the administration rate, and / or setting a maximum value for the amount of adjustment of the administration rate.
[0049] Figure 4 shows an exemplary embodiment of the computer software, i.e., the first management algorithm. A PID controller may be used to determine the infusion rate change based on the target values of vital signs, the current values of vital signs, and optionally the patient's blood pressure history. The resulting value may be multiplied by a drug scalar to arrive at the infusion rate change value, and this change value and the current infusion rate may be combined to generate a modified infusion rate. The modified infusion rate may be analyzed by a rule engine to confirm the safety of the new infusion rate for the patient, which may be done, for example, by implementing some or all of the safety precautions described above.
[0050] An exemplary rule engine is shown in Figure 5. As shown in the figure, the modified dosing rate calculated using the control algorithm may be analyzed to confirm that the modified dosing rate is safe for the patient. Although shown in a specific order in the figure, the order of analysis may vary, as long as it does not deviate from the scope of the present invention.
[0051] As shown in the diagram, the elapsed time since the last change in the drug administration rate may be monitored. Once the modified administration rate is calculated, the elapsed time may be compared to a first threshold. If the elapsed time is shorter than the first threshold, the administration rate is not adjusted (no change). If the elapsed time is greater than or equal to the first threshold, the administration rate is adjusted, provided that all other programmed conditions are met.
[0052] The amount of adjustment to the infusion rate should also be analyzed and confirmed to be greater than the minimum value and less than the maximum value. This helps ensure that no adjustment is made unless it exceeds the minimum amount possible by the infusion device (e.g., minimum change). Furthermore, this ensures that any adjustment to the infusion rate is made gradually in stages, rather than making large changes in a short period of time. If the adjustment amount is between the two values, the infusion rate will be adjusted, provided all other programmed conditions are met. If the adjustment amount is not between the two values, the infusion rate will not be adjusted (no change).
[0053] The modified infusion rate may also be compared to the minimum and maximum infusion rates to ensure that the modified infusion rate does not fall outside these thresholds. If the modified infusion rate is between the two values, the infusion rate is adjusted, provided all other programmed conditions are met. If the modified infusion rate is not between the two values, the infusion rate is not adjusted (no change).
[0054] Figure 6 shows a comparison of manual management of a patient's blood pressure with automated management using the closed-loop system and method described herein. As shown in the figure, the time spent within the target range with automated management (95%) significantly exceeded the time spent within the target range with manual management (46% and 59%). The time spent within the target range is calculated by determining how long the patient's blood pressure remained within ±5 mmHg of the set target value for that patient during a specified period of time.
[0055] Furthermore, results from using the closed-loop system and method described herein showed that the total dose of vasopressors administered to patients using the closed-loop system and method was 40% less than that administered manually to patients (control group). In addition, the median adjustment of the vasopressor administration rate using the closed-loop system exceeded 1000 times per patient, compared to 15 times per patient in the control group.
[0056] The percentage of time during surgery in which patients experienced hypotension (defined as MAP below 90% of the patient's baseline MAP) was 1.2% in patients using closed-loop systems and methods, compared to 21.5% in patients using manual management. The percentage of time during surgery in which MAP was below 65 mmHg was also lower in patients using closed-loop systems than in the control group (0% compared to 1.9% on average). Patients using closed-loop systems and methods were within the target MAP range (±10 mmHg of the patient's baseline MAP) for an average of 97.2% of the surgery time, compared to an average of 58.8% in patients under manual management. The percentage of time during surgery in which patients experienced hypertension (defined as MAP more than 10 mmHg above the MAP target) was also lower in patients using closed-loop systems and methods than in the control group using manual management (2.5% compared to 12.9% on average).
[0057] As used in this invention, and unless otherwise specified, the phrase "coupled to" encompasses both direct coupling (where the two elements being coupled are in contact with each other) and indirect coupling (where at least one additional element is placed between the two elements). Therefore, "coupled to" and "coupled with" are used interchangeably.
[0058] In some embodiments, numerical values representing properties such as measured values, component amounts, concentrations, and reaction conditions, used to describe and claim specific embodiments of the present invention, should be understood to be modified in some cases with the word "about." Accordingly, in some embodiments, the numerical parameters described herein and in the appended claims are approximations that may vary depending on the desired properties to be obtained by the particular embodiment. In some embodiments, the numerical parameters should be constructed in light of the reported number of significant figures and by applying common rounding techniques. Although the numerical ranges and parameters describing a wide range of embodiments of the present invention are approximations, the numerical values described in a particular example are reported as accurately as possible. The numerical values shown in some embodiments of the present invention may contain some degree of error, which is necessarily due to the standard deviation observed in each test measurement.
[0059] Unless the context indicates otherwise, all ranges described herein should be interpreted as encompassing their endpoints, and open-ended ranges should be interpreted as encompassing only commercially useful values. Similarly, all value sequences should be considered to encompass intermediate values unless the context indicates otherwise.
[0060] In this specification, and throughout the subsequent claims, unless the context clearly indicates otherwise, the meanings of “a,” “an,” and “the” encompass plural references. Also, in this specification, unless the context clearly indicates otherwise, the meaning of “in” encompasses “in” and “on.”
[0061] The descriptions of value ranges in this specification are merely intended as a simple way to refer individually to each discrete value that falls within that range. Unless otherwise specified herein, each individual value having a range is incorporated herein as if it were described individually. All methods described herein may be performed in any preferred order unless otherwise specifically noted herein or if it is clearly inconsistent with the context. Any examples or illustrative phrases given herein with respect to a particular embodiment (e.g., "such as") are intended solely to further illustrate the invention and not to limit its scope unless otherwise specifically asserted. Nothing in this specification should be construed as indicating that any unclaimed element is essential to the practice of the invention.
[0062] The grouping of alternative elements or embodiments of the Invention disclosed herein should not be construed as limiting. Each member of a group may be referenced and claimed individually, or in any combination with other members of that group or other elements herein. For convenience and / or patentability, one or more members of a group may be included in or removed from a group. If any such inclusion or removal occurs, this specification is deemed to satisfy the written description of the Markush groups used in the appended claims by including those groups as modified.
[0063] As will be obvious to those skilled in the art, many more modifications are possible in addition to those described herein, as long as they do not deviate from the inventive concept described herein. Therefore, the subject matter of the present invention should not be limited except to the limitations set forth in the spirit of the appended claims. Furthermore, in interpreting both this specification and the claims, all terms should be interpreted as broadly as possible while being consistent with the context. In particular, the terms “comprises” and “comprising” should be interpreted as non-exclusively referring to elements, components, or steps, meaning that the referenced elements, components, or steps may exist with, be used with, or be combined with other elements, components, or steps that are not explicitly referenced. Where a claim in this specification refers to at least one selected from the group consisting of A, B, C, ..., and N, the sentence should be interpreted as requiring only one element from the group, and not A and N, or B and N, etc.
Claims
1. 1. A method for regulating the flow of a drug to a patient, comprising: receiving information from a first source representing a current value of a first vital sign of the patient; receiving a target value or range for the first vital sign; receiving and storing a first administration rate of a medication to be administered to the patient; generating a modified administration rate for delivery of the medication to the patient using a first management algorithm if the information representing the current value of the first vital sign is outside of the target range, the first management algorithm comprising: comparing the information representative of the current value of the first vital sign with the target value or target range to calculate a difference value; calculating a dose adjustment based on the difference value and a drug scalar value; generating the revised administration rate as a function of the dose adjustment and the first administration rate; generating the modified dose rate, delivering the medication to the patient according to the modified administration rate; storing said modified dose rate; analyzing a set of prior administration rates of the drug to the patient, the set including the first administration rate; generating an alarm command if the frequency of changes in the preceding administration rate over a period of time exceeds a predetermined threshold; The method includes:
2. The method of claim 1 , wherein the first vital sign comprises a mean arterial pressure of the patient and the first source comprises a transducer attached to the patient.
3. The step of generating the modified dose rate further comprises: determining whether a first time period has exceeded a minimum time period prior to the step of delivering the medication to the patient in accordance with the modified administration rate, the first time period being defined as the time elapsed since the last administration rate change; if the first time period is less than the minimum time period, setting the modified delivery rate to the first delivery rate; if the first time period is greater than the minimum time period, delivering the medication to the patient according to the modified administration rate; Including, The minimum time is equal to or greater than the pipeline delay. The method of claim 1.
4. Receiving a minimum administration rate and a maximum administration rate. Further comprising: The first management algorithm further comprises: determining whether the modified dose rate is greater than the minimum dose rate and less than the maximum dose rate; If not, (i) setting the modified administration rate to the first administration rate, (ii) maintaining the first administration rate and delivering the medication to the patient according to the first administration rate, and (iii) generating an alarm status. Including, The method of claim 1.
5. The first management algorithm further comprises: calculating a difference between the modified administration rate and the first administration rate prior to the step of delivering the medication to the patient according to the modified administration rate; if the difference exceeds an upper change threshold, setting the modified administration rate to the first administration rate plus the upper change threshold; The method of claim 1 , comprising:
6. receiving information regarding the first vital sign from a second source, the second source including a blood pressure monitor configured to monitor a systolic blood pressure of the patient; comparing the information regarding the first vital sign received from the first and second sources; generating an alarm command if the difference in the first vital sign measured from the first and second sources exceeds a predetermined threshold; The method of claim 1 further comprising:
7. The method of claim 1, wherein the agent comprises a vasopressor.
8. The method of claim 7, wherein the first vital sign includes the patient's mean arterial pressure, and the first management algorithm is configured to generate the corrective administration rate to maintain the first vital sign within 5 mmHg of the target value.
9. A method comprising: receiving a flow rate of a carrier fluid; calculating a management delay based on the flow rate of the transport fluid; setting a minimum time equal to said pipeline delay; Further comprising: and generating the modified dose rate further comprises initially determining whether a first time, measured as the time elapsed since the last dose rate change, exceeds the minimum time. The method of claim 1.
10. A non-transitory computer readable medium having stored thereon a computer program, the computer program including commands to cause a processor of a server to implement a method for regulating a flow rate of a drug to a patient, the method comprising: receiving, by a management unit, information from a first source representative of a first vital sign of the patient; receiving, by the management unit, a target value for the first vital sign; receiving, by the management unit, a first administration rate of a medication to be administered to the patient and storing the first administration rate; the management unit comparing a current value of the first vital sign with the target value to calculate a difference value; calculating, by the management unit, a dose adjustment based on the difference value and a medication scalar value; generating, by the management unit, a revised administration rate for delivery of the medication to the patient as a function of the first administration rate and the dose adjustment, using a computer program; storing the modified dose rate in the non-transitory computer readable medium; analyzing a set of administration rates of the drug to the patient, the set including the first administration rate; generating an alarm command if the frequency of changes in the administration rate over a period of time exceeds a predetermined threshold; delivering the medication to the patient according to the modified administration rate; Including, Non-transitory computer-readable medium.
11. The non-transitory computer-readable medium of claim 10, wherein the first vital sign includes a mean arterial pressure of the patient and the first source includes a transducer attached to the patient.
12. The step of generating the modified administration rate further comprises: determining whether a first time period has exceeded a minimum time period prior to the step of delivering the medication to the patient in accordance with the modified administration rate, the first time period being defined as the time elapsed since the last administration rate change; if the first time period is less than the minimum time period, setting the modified delivery rate to the first delivery rate; if the first time period is greater than the minimum time period, delivering the medication to the patient according to the modified administration rate; Including, The minimum time is equal to or greater than the pipeline delay. The non-transitory computer-readable medium of claim 10.
13. The method further comprising: receiving a minimum administration rate and storing said minimum administration rate in said non-transitory computer readable medium; receiving a maximum administration rate and storing said maximum administration rate in said non-transitory computer readable medium; determining whether the modified dose rate is greater than the minimum dose rate and less than the maximum dose rate; If not, (i) setting the modified administration rate to the first administration rate, (ii) delivering the medication to the patient according to the first administration rate, and (iii) generating an alarm command.
11. The non-transitory computer-readable medium of claim 10, comprising:
14. The method further comprising: calculating a difference between the modified administration rate and the first administration rate prior to the step of delivering the medication to the patient according to the modified administration rate; if the difference exceeds an upper change threshold, setting the modified administration rate to the first administration rate plus the upper change threshold; 11. The non-transitory computer-readable medium of claim 10, comprising:
15. The method further comprising: receiving information regarding the first vital sign from a second source, the second source including a blood pressure monitor configured to monitor a systolic blood pressure of the patient; comparing the information regarding the first vital sign received from the first and second sources; generating an alarm command if the difference in the first vital sign measured from the first and second sources exceeds a predetermined threshold; The non-transitory computer-readable medium of claim 10 , further comprising:
16. The non-transitory computer-readable medium of claim 10, wherein the medication comprises a vasopressor, the first vital sign comprises the patient's mean arterial pressure, and the first management algorithm is configured to generate the modified administration rate to maintain the first vital sign within 5 mmHg of the target value.
17. The method further comprising: receiving a flow rate of a carrier fluid; calculating a management delay based on the flow rate of the transport fluid; setting a minimum time equal to said pipeline delay; Further comprising: and generating the modified dose rate further comprises initially determining whether a first time, measured as the time elapsed since the last dose rate change, exceeds the minimum time. The non-transitory computer-readable medium of claim 10.
18. A system for regulating the flow of a drug to a patient, comprising: A management unit including a processor and a memory communicatively coupled to the processor, the memory storing a first management algorithm, the management unit. Including, The management unit is configured to receive information regarding a first vital sign of a patient from a first source; The management unit is further configured to receive a target value or range for the first vital sign and a first administration rate for delivery of a medication to the patient; the management unit generating a revised dosage rate for delivery of the medication to the patient using the first management algorithm; the management unit sending a command signal to cause the medication to be delivered to the patient at the modified dosing rate; The first management algorithm comprises: comparing a current value of the first vital sign with the target value or range to calculate a difference value; calculating a dose adjustment based on the difference value and a drug scalar value; generating the revised administration rate as a function of the dose adjustment and the first administration rate; Including, The management unit further comprises: storing the first dose rate and the modified dose rate; analyzing a set of administration rates of the drug to the patient; Generate an alarm command if the frequency of changes in the administration rate over a period of time exceeds a predetermined threshold. It is configured as follows: system.
19. The system of claim 18, wherein the first vital sign includes a mean arterial pressure of the patient and the first source includes a transducer attached to the patient.
20. The management unit further comprises: determining whether a first time period has exceeded a minimum time period prior to the step of delivering the medication to the patient in accordance with the modified administration rate, the first time period being defined as the time elapsed since the last administration rate change; if the first time period is less than the minimum time period, setting the modified delivery rate to the first delivery rate; if the first time period is greater than the minimum time period, delivering the medication to the patient according to the modified administration rate; and configured to generate the corrected dose rate by The minimum time is equal to or greater than the pipeline delay.
20. The system of claim 18.
21. The management unit further comprises: receiving a minimum dose rate and a maximum dose rate; determining whether the modified dose rate is greater than the minimum dose rate and less than the maximum dose rate; If not, (i) setting the modified administration rate to the first administration rate, (ii) maintaining the first administration rate and delivering the medication to the patient according to the first administration rate, and (iii) generating an alarm command.
4. The method according to claim 1, 20. The system of claim 18.
22. The management unit further comprises: calculating a difference between the modified administration rate and the first administration rate prior to the step of delivering the medication to the patient according to the modified administration rate; if the difference exceeds an upper change threshold, setting the modified administration rate to the first administration rate plus the upper change threshold; 4. The method according to claim 1, 20. The system of claim 18.
23. The management unit further comprises: receiving information regarding the first vital sign from a second source, the second source including a blood pressure monitor configured to monitor a systolic blood pressure of the patient; comparing the information regarding the first vital sign received from the first and second sources; generating an alarm command if the difference in the first vital sign measured from the first and second sources exceeds a predetermined threshold; 4. The method according to claim 1, 20. The system of claim 18.
24. The system of claim 18, wherein the medication comprises a vasopressor, the first vital sign comprises the patient's mean arterial pressure, and the first management algorithm is configured to generate the modified administration rate to maintain the first vital sign within 5 mmHg of the target value.
25. The management unit further comprises: receiving a flow rate of a carrier fluid; calculating a management delay based on the flow rate of the transport fluid; setting a minimum time equal to said pipeline delay; [0023] The present invention is configured to said step of generating said modified dose rate further includes the step of first determining whether a first time, measured as the time elapsed since the last dose rate change, exceeds said minimum time.
20. The system of claim 18.
26. The management unit further comprises: prior to said step of generating said modified administration rate, comparing said information regarding a first vital sign to stored vital signs representative of vital signs prior to receiving said first vital sign; if the first vital sign is equal to the stored vital sign, setting the modified administration rate to the first administration rate; 4. The method according to claim 1, 20. The system of claim 18.
